← Open Payments lookup

RADU KRAMER: Open Payments

NPI 1326036898 · PARAMUS, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$693 in 21 payments from 9 companies in 2025. Trend: 2023 $811 · 2024 $1,097 · 2025 $693

Food & beverage: $693
CompanyPaymentsAmount
ABBVIE INC.10$310
Neurocrine BioSciences, Inc.1$120
Lilly USA, LLC1$117
Amgen Inc.4$62
Eisai Inc.1$22
PFIZER INC.1$18
Otsuka America Pharmaceutical, Inc.1$17
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$14
Novo Nordisk Inc1$14

Products named: VRAYLAR, INGREZZA, ZEPBOUND, OTEZLA, Leqembi, VIBERZI, PAXLOVID, CREON.

Industry payments across NJ — which companies pay providers there.